Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is a combination diabetes control medication. Its two components work together to lower blood sugar levels and improve insulin effectiveness.

Question 2

When and how should this medicine be taken?

Accepted Answer

• Take with meals to reduce stomach upset • Take regularly at the same time each day

Question 3

When should this medicine not be used?

Accepted Answer

• Do not use in kidney failure • Do not use in severe liver disease • Do not use if you have lactic acidosis

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Risk of lactic acidosis - stop if severe illness occurs • Monitor kidney function regularly • Watch for signs of pancreatitis • May lower vitamin B12 levels - check annually

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Limited data available on use during pregnancy • Use only if potential benefit outweighs potential risk • May affect blood sugar control

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Risk of lactic acidosis - stop if severe illness occurs • Monitor kidney function regularly • Watch for signs of pancreatitis • May lower vitamin B12 levels - check annually

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • For twice-daily dosing: If more than 4 hours until your next dose, take the missed dose. • Take your next dose at the regular time. • If you miss multiple doses, contact your doctor.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Symptoms: Hypoglycemia, lactic acidosis. • Treatment: Glucose administration, dialysis.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Low blood sugar (with sulfonylurea), nasal infection, diarrhea, decreased appetite, nausea • What to do: Regular blood sugar monitoring; Take with meals; Report persistent nausea; Stay hydrated; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What medical indications are treated with Linagliptin + Metformin Hydrochloride?

Accepted Answer

Linagliptin + Metformin Hydrochloride (Combination Oral Hypoglycemic Preparations) is a pharmaceutical active substance. It is indicated for the treatment of Diabetes Mellitus Type 2.

Question 11

What is the recommended dosage for Linagliptin + Metformin Hydrochloride?

Accepted Answer

Standard adult dosage: Prompt-release tablets – 2.5 mg/500 mg (twice daily). Pediatric dosage: Not Specified – Not Specified. Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 12

Is Linagliptin + Metformin Hydrochloride safe during pregnancy and breastfeeding?

Accepted Answer

Linagliptin + Metformin Hydrochloride is classified under Pregnancy Category "Not Assigned". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 13

What are the common side effects of Linagliptin + Metformin Hydrochloride?

Accepted Answer

**More than 10%**; Hypoglycemia (with sulfonylurea) (22.9%); **1-10%**; Nasopharyngitis (6.3%);Diarrhea (6.3%);Hypoglycemia (without sulfonylurea) (1.4%); **Frequency Not Defined**; Hypersensitivity (eg urticaria, angioe

Clinical Information	Administration Information
Indication: Type 2 diabetes mellitus Age: Adult Condition: Initial dose, not currently taking metformin	Dose: Prompt-release tablets – 2.5 mg/500 mg Frequency: twice daily Note: Administer by mouth. Used as an adjunct to diet and exercise to improve glycemic control when treatment with both linagliptin and metformin is appropriate.
Indication: Type 2 diabetes mellitus Age: Adult Condition: Initial dose, already taking metformin	Dose: Prompt-release tablets – 2.5 mg of linagliptin and a dose based on current metformin dose Frequency: twice daily Note: Administer by mouth. Example: if taking metformin 1000 mg twice daily, initiate with 2.5 mg/1000 mg by mouth twice daily. Total dose not to exceed 2.5 mg/1,000 mg twice daily.

Clinical Information	Administration Information
Condition: Renal impairment with eGFR less than 30 mL/min/1.73 m2	Dose: Tablet – Not specified Note: Contraindicated. Discontinue drug if eGFR falls below this level while taking metformin.
Condition: Renal impairment with eGFR 30-45 mL/min/1.73 m2	Dose: Tablet – Not specified Note: Not recommended to initiate treatment. If eGFR falls below 45 mL/min/1.73 m2 while taking metformin, risks and benefits of continuing therapy should be evaluated.

Drug Name	Risk Factors
Digoxin	Linagliptin inhibits P-glycoprotein-mediated transport (with low potency)
Ritonavir	Increased AUC & Cmax of linagliptin

Disease Name	Risk Factors
Type 1 Diabetes	Not effective for Type 1 diabetes
Diabetic Ketoacidosis	Risk of metabolic complications

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Renal Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources